medigraphic.com
Anales de la Sociedad Mexicana de Oftalmología y Archivos de la Asociación Para Evitar la Ceguera en México

2010, Number 2

<< Back Next >>

Rev Mex Oftalmol 2010; 84 (2)

Estudio comparativo de alteraciones sistémicas en pacientes diabéticos sin retinopatía y con retinopatía proliferativa

Salcedo-Villanueva G, Figueroa-Magaña BB, Díaz-Robles D, León-Ortiz P

Language: Spanish
References: 19
Page: 82-85
PDF size: 83.05 Kb.


ABSTRACT

The second most common form of handicap in people over 60 years of age with diabetes is visual manifestations of the disease. It is the leading cause of blindness in México and many developing countries. The most important risk factors for proliferative diabetic retinopathy are the duration of the disease and glycated hemoglobin. In univariated analysis high levels of cholesterol have been associated with diabetic maculopathy. Levels of urinary albumin were associated with the development of diabetic retinopathy in type 1 diabetics, as opposed to what was found on type 2 diabetics.
Materials and methods: A retrospective, observational, transversal and comparative study was realized. We analyzed the results of preoperative tests of 200 patients; 124 of who were diagnosed with cataract and had no diabetic retinopathy and who underwent cataract surgery; the other 76 had proliferative diabetic retinopathy and underwent vitrectomy.
Results: There is clinical significant difference in hepatic and renal function.
Conclusions: Mexican diabetic patients show a poor glycemic control done in primary care institutions. Patients with proliferative diabetic retinopathy are an economically active population and probably have some degree of renal failure.


REFERENCES

  1. www.inegi.gob.mx

  2. Wang PH, Lau J, Chalmers TC. Meta-analysis of effects of intensive blood-glucose control on late complications of type 1 diabetes. Lancet 1993; 341:1306-1309.

  3. DCCT group. Progression of retinopathy with intensive versus conventional treatment in the diabetes control and complications trial. Ophthalmology 1995; 102:647-661.

  4. Klein R, Klein BEK, Moss SE, Davids MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy II – prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984; 102:520-526.

  5. Porta M, Sjoelie AK, Chaturvedi N, Stevens L, Rottiers R, Veglio M y cols. Risk factors for progression to proliferative diabetic retinopathy in the EURODIAB prospective complications study. Diabetologia 2001; 44:2203-2209.

  6. Keen H, Lee ET, Russell D, Miki E, Bennett PH, Lu M. The appearance of retinopathy and progression to proliferative retinopathy: the WHO multinational study of vascular disease in diabetes. Diabetologia 2001; 44(Suppl 2):S22-S30.

  7. Fong DS, Ferris FL, Davis MD, Chew EY. Causes of severe visual loss in the early treatment diabetic retinopathy study: EDTRS report no 24. Early Treatment Diabetic Retinopathy Study Report. Am J Ophthalmol 1999; 127:137-141.

  8. Davis MD, Fisher MR, Gangnon RE, Barton F, Aiello LM, Chew EY y cols. Risk factors for high-risk diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18. Invest Ophthalmol Vis Sci 1998; 39:233-252.

  9. Savage S, Estacio RO, Jeffers B, Schrier RW. Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy and cardiovascular disease in NIDDM. Diab Care 1996;19:1243-1248.

  10. Flegal KM, Ezzati TM, Harris MI, Haynes SG, Juarez RZ y cols. Prevalence of diabetes in Mexican-Americans, Cubans, and Puerto Ricans for the Hispanic Health and Nutrition Examination Survey, 1982-1984. Diabetes Care 1991; 14(Suppl. 3):628-638.

  11. Stern MP, Rosenthal M, Haffner SM, Hazuda HP, Franco LJ. Sex differences in the effects of sociocultural status on diabetes and cardiovascular risk factors in Mexican-Americans: the San Antonio Heart Study. Am J Epidemiol 1984; 120:834-851.

  12. Hamman RF, Marchall JA, Baxter J, Kahn LR y cols. The San Luis Valley Diabetes Study methods and prevalence of noninsulindependent diabetes mellitus (NIDDM): a biethnic Colorado population. Am J Epidemiol 1989; 129:295-311.

  13. Stern M, Michell B. Diabetes in America. Washington, DC, U.S. Govt. Printing Office, 1995, p. 631-659 (NIH publ. no. 95-1468).

  14. Stern MP, Gonzalez C, Mitchell BD, Villalpando E, Haffner SM, Hazuda HP: Genetic and environmental determinants of type II diabetes in Mexico City and San Antonio. Diabetes 1992;41:484-492.

  15. Haffner SM, Rosenthal M, Hazuda HP, Stern MP, Franco LJ. Evaluation of three potential screening test for diabetes mellitus in a biethnic population. Diabetes Care 1984; 7:347-353.

  16. West SK, Klein R, Rodriguez J, Muñoz B, Broman AT y cols. Diabetes and diabetic retinopathy in a Mexican-American population. Proyecto VER. Diabetes Care 2001; 24:1204-1209.

  17. Yu T, Mitchel P, Berry G, Li W, Wang JJ. Retinopathy in olderpeople without diabetes and its relationship to hypertension.Arch Ophthalmol 1998;116:83-89.

  18. Klein R. Retinopathy in a population-based study. Trans AmOphthalmol Soc 1992; 90:561-594.

  19. West SK, Munoz B, Klein R, Broman AT y cols. Risk factors for type II diabetes and diabetic retinopathy in a Mexican-American population: Proyecto VER. Am J Ophthalmol 2002;134:390-398.




2020     |     www.medigraphic.com